What's the Value Added?
Every year, an estimated 22.6 million patients suffer from neurological disorders or injuries that warrant the expertise of a neurosurgeon.
In the U.S, there is an estimated case volume of 664,698 cases and 5296 active surgeons.
The product's added value will be reduced surgical times and reducing patient complication
Who are we trying to reach?
How do we reach them?
Our strategy for marketing is to contact hospital systems directly
- This method will develop relationships with clients and help the DURALine spread to other customers by word of mouth.
- Contacting the customer through surveying and receiving feedback will help optimize the DURALine for future models as well as to help Haptech Surgical improve patient outcomes and surgeon precision and control.
Who are our partners?
Cost Structures and Revenues
Haptech has spent time conceptualizing designs and prototypes. Moving forward, the next steps are product testing and clinical testing.